Ozempic and the Return of Diet Culture: A Weight-Inclusive, Eating Disorders-Informed Perspective on GLP-1s
Over the past few years, medications like Ozempic, Wegovy, and Mounjaro have become a major part of conversations about health, food, and body size. What began as medications developed for specific medical purposes has evolved into a much broader cultural conversation about weight loss, appetite suppression, and the pursuit of smaller bodies.
For some people, GLP-1 medications offer meaningful medical benefits and are an important part of managing chronic health conditions. For others, the growing popularity of these medications has brought renewed pressure to lose weight, eat less, or view a smaller body as the ultimate marker of health and success.











